A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing weight and improving blood pressure and other […]
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its forecast for 2024 well beyond analyst expectations after sales of Mounjaro more than tripled in the year’s first quarter. Lilly said it was still dealing with supply […]
Eli Lilly (LLY) jumped early Tuesday after the pharma behemoth reported adjusted earnings of $2.58 per share on $8.77 billion in first-quarter sales. X On average, analysts polled by FactSet expected Lilly to earn $2.47 per share on $8.94 billion in sales. The company also reported $517.4 million in sales of weight-loss drug Zepbound, whereas […]
You may not expect a pharmaceutical stock to mimic the behavior of the latest hot growth stock and soar in the triple digits over 12 months. But Eli Lilly (NYSE: LLY) did it, climbing nearly 117% over the past year. This wasn’t just a random happening, but instead evidence investors are very excited about what’s […]
Ozempic Seemingly bad news can sometimes be really good news. I think a recent study for Eli Lilly‘s (NYSE: LLY) rival to Novo Nordisk‘s massively successful Ozempic and Wegovy provides a great case in point. Results from the Surmount-4 clinical trial were published on the Journal of the American Medical Association‘s website on Dec. 11, […]
By Robin Foster HealthDay Reporter (HealthDay) WEDNESDAY, Dec. 6, 2023 (HealthDay News) — The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda […]
By Robin Foster HealthDay Reporter (HealthDay) WEDNESDAY, Dec. 6, 2023 (HealthDay News) — The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda […]